SCHEMBL3086072

SCHEMBL3086072

COC(C)c1ccc(Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.52
SLC6A4 P31645 2/20 0.46
AOC3 Q16853 1/20 0.46
AKR1C2 P52895 1/20 0.44
AKR1C1 Q04828 1/20 0.44
IDO1 P14902 3/20 0.43
TDO2 P48775 3/20 0.43
CYP19A1 P11511 2/20 0.43
TSHR P16473 2/20 0.42
MAPK1 P28482 2/20 0.42
HIF1A Q16665 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
LMNA P02545 2/20 0.41
TP53 P04637 1/20 0.41
HPGD P15428 1/20 0.41
CYP2A6 P11509 1/20 0.40
ALOX15 P16050 1/20 0.40
BRD4 O60885 1/20 0.39
FFAR2 O15552 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17771762 1.00 ADRB2 (0.52) ADRB2SLC6A4AOC3AKR1C2AKR1C1
SCHEMBL15854056 1.00 ADRB2 (0.52) ADRB2SLC6A4AOC3AKR1C2AKR1C1
SCHEMBL1338710 0.87 AKR1C2 (0.42) ADRB2SLC6A4AOC3AKR1C2AKR1C1
SCHEMBL8750439 0.84 IDO1 (0.43) AKR1C2AKR1C1IDO1MAPK1HIF1A
SCHEMBL17789895 0.84 ADRB2 (0.46) ADRB2SLC6A4AOC3IDO1TDO2
SCHEMBL29671642 0.78 ADRB2 (0.50) ADRB2SLC6A4AOC3IDO1TDO2
SCHEMBL8614780 0.78 IDO1 (0.58) ADRB2SLC6A4AOC3IDO1TDO2
SCHEMBL11781825 0.78 ADRB2 (0.50) ADRB2SLC6A4AOC3IDO1TDO2
SCHEMBL18905322 0.77 AKR1C2 (0.38) AKR1C2AKR1C1
SCHEMBL654510 0.77 ADRB2 (0.48) ADRB2SLC6A4AOC3IDO1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170001990-A1 PIPERIDINE-DIONE DERIVATIVES GENENTECH, INC. (US) 2017-01-05 US disclosed
US-9346805-B2 Pyrimidyl cyclopentanes as Akt protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2016-05-24 US disclosed
WO-2015140133-A1 PIPERIDINE-DIONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2015-09-24 WO disclosed
WO-2015142903-A2 METHOD OF CONTROLLING LACTATE PRODUCTION WITH PIPERDINE-DIONE DERIVATIVES GENENTECH, INC. (US) 2015-09-24 WO disclosed
US-8722942-B2 Method for producing biphenyl derivative TORAY FINE CHEMICALS CO., LTD. (JP) 2014-05-13 US disclosed
EP-2075241-B1 METHOD FOR PRODUCING A BIPHENYL DERIVATIVE TORAY FINECHEMICALS CO LTD (JP) 2013-09-25 EP disclosed
US-20100230634-A1 METHOD FOR PRODUCING BIPHENYL DERIVATIVE Hayashi, Tamio (JP) 2010-09-16 US disclosed
EP-2075241-A1 METHOD FOR PRODUCING BIPHENYL DERIVATIVE Toray Fine Chemicals Co., Ltd. (JP) 2009-07-01 EP disclosed
WO-2009034547-A2 NEW 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO[3,4-D PYRIMIDINE AND PYRROLO[2,3-D]PYRIMIDINE AND USES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2009-03-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100230634-A1 METHOD FOR PRODUCING BIPHENYL DERIVATIVE CYP2E1, DDT, B2M ADRB2 2561/4885SLC6A4 3842/4885AOC3 1215/4885
US-20170001990-A1 PIPERIDINE-DIONE DERIVATIVES DRD4, ADORA1, ADORA3 ADRB2 144/4885SLC6A4 1120/4885AOC3 1344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.